Your Health, We Care
Repotrectinib is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).
from FDA，2023.11
Adult patients with locally advanced or metastatic ROS1 positive non-small cell ···【more】
Release date：2026-01-05Recommended：0
